Matilda Dhima
Dentist, Prosthodontics Pittsburgh, PA Doctor of Dentistry
NPI 1225266943 CMS profile 654609
3501 Terrace St, Suite 3189, Pittsburgh, PA 15213
General payments
$456
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Matilda Dhima of Pittsburgh, PA is reported in the CMS Open Payments database as having received $456 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 52nd percentile of Dentist, Prosthodontics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $18 | 1 | |
| 2022 | General | $94 | 2 | |
| 2020 | General | $12 | 1 | |
| 2019 | General | $333 | 8 |
Beside peers
- Matilda Dhima
- Dentist, Prosthodontics median
- Middle half of Dentist, Prosthodontics
- National median
In program year 2025, general payments to Matilda Dhima were reported at $0. Among 1,396 Dentist, Prosthodontics profiles paid that year, the median was $118 and the middle half received between $44 and $351.
Show as a table
| Year | Matilda Dhima | Dentist, Prosthodontics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $333 | $107 | $36–$389 | $163 |
| 2020 | $12 | $100 | $41–$311 | $114 |
| 2021 | $0 | $129 | $40–$398 | $132 |
| 2022 | $94 | $129 | $47–$460 | $149 |
| 2023 | $0 | $135 | $44–$432 | $160 |
| 2024 | $18 | $142 | $45–$420 | $164 |
| 2025 | $0 | $118 | $44–$351 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
127
Drug cost
$508
Branded share of claims
25.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 66 | $168 | |
| Sodium Fluoride Fluoride (Sodium) | Brand | 16 | $148 | |
| Denta 5000 Plus Fluoride (Sodium) | Brand | 16 | $135 | |
| Amoxicillin | Generic | 29 | $57 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Prosthodontics in Pennsylvania
Evanthia Anadioti
Dentist, Prosthodontics · Philadelphia, PA
Randolph Resnik
Dentist, Prosthodontics · Pittsburgh, PA
Robert Slauch
Dentist, Prosthodontics · Fort Washington, PA
Louis Dipede
Dentist, Prosthodontics · Philadelphia, PA
Harold Baumgarten
Dentist, Prosthodontics · Philadelphia, PA
Aysegul Siranli
Dentist, Prosthodontics · Pittsburgh, PA
Related records
Dentist, Prosthodontics in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Prosthodontics
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.